Compare Shofu, Inc. with Similar Stocks
Dashboard
1
Company has very low debt and has enough cash to service the debt requirements
2
Healthy long term growth as Operating profit has grown by an annual rate 19.52%
3
Negative results in Jun 25
4
With ROE of 10.16%, it has a very attractive valuation with a 1.70 Price to Book Value
5
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
JPY 67,783 Million (Small Cap)
17.00
NA
0.00%
-0.24
10.25%
1.52
Revenue and Profits:
Net Sales:
9,506 Million
(Quarterly Results - Jun 2025)
Net Profit:
853 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.21%
0%
-10.21%
6 Months
-15.55%
0%
-15.55%
1 Year
-12.3%
0%
-12.3%
2 Years
61.23%
0%
61.23%
3 Years
110.8%
0%
110.8%
4 Years
77.25%
0%
77.25%
5 Years
120.9%
0%
120.9%
Shofu, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.19%
EBIT Growth (5y)
19.52%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.87
Tax Ratio
29.56%
Dividend Payout Ratio
40.33%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.51%
ROE (avg)
8.30%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
1.70
EV to EBIT
11.44
EV to EBITDA
9.56
EV to Capital Employed
1.94
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.98%
ROE (Latest)
10.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
9,506.00
9,853.00
-3.52%
Operating Profit (PBDIT) excl Other Income
1,766.00
1,387.00
27.33%
Interest
1.00
11.00
-90.91%
Exceptional Items
0.00
0.00
Consolidate Net Profit
853.00
846.00
0.83%
Operating Profit Margin (Excl OI)
157.40%
111.30%
4.61%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -3.52% vs -1.05% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 0.83% vs -24.53% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
38,698.00
35,080.00
10.31%
Operating Profit (PBDIT) excl Other Income
6,452.00
5,878.00
9.77%
Interest
17.00
22.00
-22.73%
Exceptional Items
0.00
-121.00
100.00%
Consolidate Net Profit
4,335.00
3,677.00
17.90%
Operating Profit Margin (Excl OI)
139.40%
134.30%
0.51%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 10.31% vs 10.74% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 17.90% vs 16.36% in Mar 2024
About Shofu, Inc. 
Shofu, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






